ARAY Key Statistics, Chart & Performance
The current stock price of ARAY is 0.62 USD. In the past month the price decreased by -30.35%. In the past year, price decreased by -74.49%.
ARAY Technical Analysis
ARAY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to ARAY. ARAY has a bad profitability rating. Also its financial health evaluation is rather negative.
ARAY Financial Highlights
Over the last trailing twelve months ARAY reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS decreased by -418% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.23% | ||
| ROE | -31.22% | ||
| Debt/Equity | 2.06 |
ARAY Forecast & Estimates
8 analysts have analysed ARAY and the average price target is 3.95 USD. This implies a price increase of 537.5% is expected in the next year compared to the current price of 0.62.
For the next year, analysts expect an EPS growth of -779.31% and a revenue growth 2.63% for ARAY
ARAY Ownership
ARAY Latest News, Press Relases and Analysis
ARAY Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.3 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.76 | 173.049B | ||
| SYK | STRYKER CORP | 23.7 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 45.675B | ||
| RMD | RESMED INC | 22.12 | 39.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 36.738B | ||
| DXCM | DEXCOM INC | 27.71 | 27.29B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ARAY
Company Profile
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Company Info
ACCURAY INC
1240 Deming Way
Madison WISCONSIN 94089 US
CEO: Joshua H. Levine
Employees: 987
Phone: 18009279800
ACCURAY INC / ARAY FAQ
What does ARAY do?
Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
What is the current price of ARAY stock?
The current stock price of ARAY is 0.62 USD. The price increased by 3.32% in the last trading session.
Does ACCURAY INC pay dividends?
ARAY does not pay a dividend.
What is the ChartMill technical and fundamental rating of ARAY stock?
ARAY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is ACCURAY INC (ARAY) stock traded?
ARAY stock is listed on the Nasdaq exchange.
What is the Price/Earnings (PE) ratio of ACCURAY INC (ARAY)?
ACCURAY INC (ARAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.26).
What is the employee count for ARAY stock?
ACCURAY INC (ARAY) currently has 987 employees.